Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Radio transmitter and radio receiver with channel condition assessment
Specializing disambiguation of a natural language expression
Data processing circuit with arbitration between a plurality of queues
Real-time virtual endoscopy
Display screen with an animated graphical user interface
  Randomly Featured Patents
Back and seat cushions for a chair
Hinge assembly, hand tool and pliers
Balustrade and deck mounting assembly for a passenger conveyor
Generating interface adjustment signals in a device-to-device interconnection system
System and method for preventing unauthorized use of a micro cellular system
Process for manufacturing phased sprocket assemblies by capacitor discharge welding
Method and apparatus for flat tube roll forming and flat tube formed thereby
Apparatus for processing bio-harzardous waste
Inflatable riding toy
Multi-layer conductor with carbon nanotubes